Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Genentech
Scientific Title
A Phase II, Open-Label, Multicenter, Randomized Study Of The Efficacy And Safety Of RO7198457 In Combination With Pembrolizumab Versus Pembrolizumab In Patients With Previously Untreated Advanced Melanoma